1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, October 2016 (p10)

Drug Discovery and Development Analysis & Statistics, October 2016 (p10)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

271-300 of about 1500 reports

Purchase Reports From Reputable Market Research Publishers

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘T Cell Surface Glycoprotein CD3 Epsilon ...

  • Industries : Therapy, Oncology, Chronic Disease, Pathology
  • Countries : World, United States, Europe
Portal Hypertension Global Clinical Trials Review, H2, 2016

Portal Hypertension Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Portal Hypertension Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Portal Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Portal Hypertension ...

  • Industries : Drug Discovery and Development, Pathology, Pharmaceutical, Chronic Disease
  • Countries : World
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016

Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H2, 2016" provides an ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Venous Thromboembolism Global Clinical Trials Review, H2, 2016

Venous Thromboembolism Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Venous Thromboembolism Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Venous ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Reperfusion Injury Global Clinical Trials Review, H2, 2016

Reperfusion Injury Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Reperfusion Injury Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H2, 2016" provides an overview of Reperfusion ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Intestinal Cancer Global Clinical Trials Review, H2, 2016

Intestinal Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Intestinal Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Intestinal Cance ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Renal Failure Global Clinical Trials Review, H2, 2016

Renal Failure Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Renal Failure Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2016" provides an overview of Renal Failure clinical ...

  • Industries : Pharmaceutical, Drug Discovery and Development
  • Countries : World
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) ...

  • Industries : Pharmaceutical, Chronic Disease, Drug Discovery and Development, Pathology, Therapy
  • Countries : World
Proteinuria Global Clinical Trials Review, H2, 2016

Proteinuria Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Proteinuria Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Proteinuria Global Clinical Trials Review, H2, 2016" provides an overview of Proteinuria clinical trials ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development, Therapy, Healthcare, Chronic Disease
  • Countries : World
Renal Stones/Calculi Global Clinical Trials Review, H2, 2016

Renal Stones/Calculi Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Renal Stones/Calculi Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2016" provides an overview of Renal Stones/Calculi ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Therapy
  • Countries : World
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World
Enterocolitis - Pipeline Review, H2 2016

Enterocolitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Enterocolitis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Enterocolitis - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Therapy, Pharmaceutical, Drug Discovery and Development, Pathology
  • Countries : United States, World
Keratitis - Pipeline Review, H2 2016

Keratitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Keratitis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keratitis - Pipeline Review, H2 2016, provides an overview of the Keratitis ...

  • Industries : Pathology
  • Countries : United States
Ageing - Pipeline Review, H2 2016

Ageing - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Ageing - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ageing - Pipeline Review, H2 2016, provides an overview of the Ageing (Metabolic ...

  • Industries : Drug Discovery and Development, Biological Therapy, Therapy, Pharmaceutical
  • Countries : World
Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2016

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Pipeline Review, H2 2016 Summary Global ...

  • Industries : Cancer, Therapy, Drug Discovery and Development, Pathology
  • Countries : World, Canada
Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Placenta Growth Factor (Vascular Endothelial Growth Facto ...

  • Industries : Pathology, Biopharmaceutical, Therapy
  • Countries : United States
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2016’, provides in depth ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
SPR Therapeutics, LLC - Product Pipeline Analysis, 2016 Update

SPR Therapeutics, LLC - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • October 2016
  • by GlobalData

Summary SPR Therapeutics, LLC (SPR Therapeutics) is a medical device company that develops and commercializes neurostimulation based therapies and medical devices. The company develops and commercializes ...

  • Industries : Therapy
  • Countries : United States
Allergic Conjunctivitis - Pipeline Review, H2 2016

Allergic Conjunctivitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Allergic Conjunctivitis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis - Pipeline Review, H2 2016, provides ...

  • Industries : Pharmaceutical, Therapy, OTC
  • Countries : United States
Epidermolysis Bullosa - Pipeline Review, H2 2016

Epidermolysis Bullosa - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Epidermolysis Bullosa - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology
  • Countries : United States
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Glycogen Synthase Kinase ...

  • Industries : Chronic Disease, Pathology, Biopharmaceutical, Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World, United States, Asia
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Healthcare
  • Countries : World, Europe, Asia
PDE Inhibitors Market, 2016-2026

PDE Inhibitors Market, 2016-2026

  • $ 2349
  • Industry report
  • October 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION The discovery of the second messengers, cAMP and cGMP, in 1958 led to a deeper understanding of the signal transduction processes behind physiological stimulation and response. Later, the ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy
  • Countries : United States
Contract Research Organizations - Industry Market Research Report

Contract Research Organizations - Industry Market Research Report

  • $ 1020
  • Industry report
  • October 2016
  • by Ibisworld

Outside knowledge: The industry will thrive as research and development budgets rise Abstract Contract Research Organizations The industry experienced a period of aggressive growth over the past five ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - ...

  • Industries : Therapy, Pharmaceutical, Drug Discovery and Development
  • Countries : World, Australia, United States
Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : World
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) ...

  • Industries : Pathology, Biological Therapy, Therapy, Cancer
  • Countries : United States
Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Lysine Specific Histone Demethylase 1A (Lysine (K) Specific Demethylase 1 or Flavin Containing Amine Oxidase Domain Containing Protein 2 or BRAF35 HDAC Complex Protein BHC110 or KDM1A or EC 1.) - Pipeline ...

  • Industries : Pathology, Cancer
  • Countries : World, Spain, United States
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) ...

  • Industries : Pathology, Biological Therapy, Therapy, Biotechnology
  • Countries : United States, World

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.